An integrated community-clinic model of optimized implementation strategies to increase early detection of breast and cervical cancers in Kenya
Project Number5R01CA269472-04
Former Number1R01CA269472-01A1
Contact PI/Project LeaderSUBRAMANIAN, SUJHA
Awardee OrganizationIMPLENOMICS LLCS
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Kenya has a high incidence of breast and cervical cancers, and most women are diagnosed with late-
stage disease. Implementing effective programs to screen and detect these cancers at an early stage could
substantially decrease the high mortality. Kenya has been increasing access to cancer screening, but less
than one-sixth of eligible women have ever received breast and cervical cancer screening.
The goal of the study is to assess the effectiveness and cost-effectiveness of multicomponent strategies
to increase the uptake of breast and cervical cancer screeening. A key gap that perpetuates the low
screening rates in Kenya is the lack of community–clinic linkages. There is evidence that women are often
unaware of the screening services offered in facilities, and, even among those who are aware, there is lack
of motivation, anticipated or perceived stigma, and reduced self-efficacy to undergo screening. We will
conduct a pragmatic cluster randomized trial to evaluate the screening outcomes, including screening
uptake, diagnostic test completion, and treatment initiation and implementation outcomes to support scale-
up. We will test two multicomponent packages of strategies: (1) Cancer Community–Clinic Linkage (C3Link)
Core: Community health volunteer (CHV)-delivered group education for women and family members to
increase screening uptake in the community setting and practice facilitation to improve the screening
process and develop team-based care with CHV participation in the clinic setting; (2) C3Link Plus: C3Link
Core strategies along with a sequential series of individual strategies that increase in intensity at 3-month
intervals; women who remain unscreened will first receive one-on-one education; second, motivational
interviewing; and, finally, navigation to address specific barriers.
We will implement the study across 27 communities in Kenya to address the following three specific
aims: Aim 1: Conduct a cluster randomized trial to assess short-term (intervention implementation phase)
and longer-term impacts (maintenance phase) of the two packages of multicomponent strategies on breast
and cervical cancer screening outcomes along the continuum of care compared to enhanced standard of
care (communities receiving a messaging campaign only); Aim 2: Use a mixed-methods approach to assess
and compare multilevel implementation outcomes of the package of strategies focusing on acceptability,
feasibility, appropriateness, fidelity, and sustainability; Aim 3: Perform cost-effectiveness and return-on-
investment analysis to support scale-up of an effective package of implementation strategies across Kenya
and other sub-Saharan African countries. The Kenyan Ministry of Health can use the findings from this study
to design optimal approaches and plan investments in screening infrastructure to scale up implementation of
guideline recommendations. The lessons learned can be applied to other sub-Saharan African settings.
Public Health Relevance Statement
PROJECT NARRATIVE
Kenya has a high incidence of breast and cervical cancers, and most women are diagnosed with late-stage
disease. We will conduct a study to assess the effectiveness and cost-effectiveness of strategies to increase
the uptake of cancer screening and completion of recommended diagnostic and treatment services. The
findings can be used to design optimal approaches and plan investments in infrastructure to scale up
implementation of breast and cervical cancer screening.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdoptedAfricanAwarenessBehavioralBreast Cancer DetectionBreast Cancer Early DetectionCancer ControlCancer DetectionCatchment AreaCervical Cancer ScreeningClinicCluster randomized trialCommunicationCommunitiesCommunity HealthCommunity PracticeContinuity of Patient CareCost Effectiveness AnalysisCountryDNADataDiagnosticDiagnostic ServicesDiagnostic testsDiseaseEducationEligibility DeterminationEnsureFamily memberFosteringFundingFutureGoalsGrantGuidelinesHealthHealth Care FacilityHealth systemHuman PapillomavirusIncidenceIndividualInfrastructureInvestmentsKenyaMaintenanceMalignant Breast NeoplasmMalignant NeoplasmsMalignant neoplasm of cervix uteriMammographyMethodsModelingMotivationNational Cancer InstituteOutcomePap smearPathway interactionsPatientsPhasePlayPopulationProceduresProcessProgram EfficiencyRecommendationResearchResourcesRoleScreening for cancerSelf EfficacySeriesServicesTestingWomanWomen's studyagedcancer carecommunity cliniccommunity clinical linkagecommunity settingcost effectivenesscost efficientdesigneffectiveness evaluationempowermentevidence basefollow-upimplementation evaluationimplementation facilitatorsimplementation interventionimplementation outcomesimplementation strategyimprovedimproved outcomemortalitymotivational enhancement therapymultimodalityoptimal treatmentspolicy implicationpostersprocess improvementprogramsscale upscreeningscreening servicessocial stigmastandard of careteam-based caretheoriestreatment servicesuptakevolunteerwomen's diagnosis
No Sub Projects information available for 5R01CA269472-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01CA269472-04
Patents
No Patents information available for 5R01CA269472-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01CA269472-04
Clinical Studies
No Clinical Studies information available for 5R01CA269472-04
News and More
Related News Releases
No news release information available for 5R01CA269472-04
History
No Historical information available for 5R01CA269472-04
Similar Projects
No Similar Projects information available for 5R01CA269472-04